Effect of Weight Loss (WL) on Concomitant Medication Costs in Obese/Overweight individuals with Metabolic Syndrome (METS) receiving Phentermine/Topiramate extended-release (PHEN/TPM ER)
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1730
https://www.valueinhealthjournal.com/article/S1098-3015(15)01787-8/fulltext
Title :
Effect of Weight Loss (WL) on Concomitant Medication Costs in Obese/Overweight individuals with Metabolic Syndrome (METS) receiving Phentermine/Topiramate extended-release (PHEN/TPM ER)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01787-8&doi=10.1016/j.jval.2015.03.1730
First page :
A297
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
1210